Home » Angiotech CEO Says Recap Plan Best Alternative
Angiotech CEO Says Recap Plan Best Alternative
A plan by Angiotech Pharmaceuticals Inc. to form a new subsidiary and raise up to $300 million in a notes offering to reduce debt is the best alternative in a "horrific" financing environment, the company's chief executive says.
Canadian Business
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May